| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769726 | American Journal of Kidney Diseases | 2018 | 9 Pages |
Abstract
Eculizumab appears to be a potential treatment for patients with crescentic rapidly progressive C3 glomerulopathy. Its benefit in patients with non-rapidly progressing forms seems to be limited.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Moglie Le Quintrec, Anne-Laure Lapeyraque, Arnaud Lionet, Anne-Laure Sellier-Leclerc, Yahsou Delmas, Véronique Baudouin, Eric Daugas, Stéphane Decramer, Leila Tricot, Mathilde Cailliez, Philippe Dubot, Aude Servais, Catherine Mourey-Epron,